The purpose of this research study is to evaluate the effect of low-dose aspirin on recovery
from severe preeclampsia (a high blood pressure disorder of pregnancy) among women who have
given birth. We hypothesize that taking aspirin for the first week after giving birth will
enhance recovery from preeclampsia by decreasing the levels of a protein called soluble
fms-like tyrosine kinase (sFlt-1), which is thought to be a main contributor to the
development of preeclampsia, and speeding up return to a normal blood pressure.